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Background: Umbilical and epigastric hernia repairs are frequently performed surgical procedures with
an expected low complication rate. Nevertheless, the optimal method of repair with best short- and
long-term outcomes remains debatable. The aim was to develop guidelines for the treatment of umbilical
and epigastric hernias.
Methods: The guideline group consisted of surgeons from Europe and North America including mem-
bers from the European Hernia Society and the Americas Hernia Society. The Grading of Recom-
mendations, Assessment, Development and Evaluation (GRADE) approach, the Scottish Intercollegiate
Guidelines Network (SIGN) critical appraisal checklists, and the Appraisal of Guidelines for Research
and Evaluation (AGREE) instrument were used. A systematic literature search was done on 1 May 2018,
and updated on 1 February 2019.
Results: Literature reporting specifically on umbilical and epigastric hernias was limited in quantity
and quality, resulting in a majority of the recommendations being graded as weak, based on low-quality
evidence. The main recommendation was to use mesh for repair of umbilical and epigastric hernias to
reduce the recurrence rate. Most umbilical and epigastric hernias may be repaired by an open approach
with a preperitoneal flat mesh. A laparoscopic approach may be considered if the hernia defect is large,
or if the patient has an increased risk of wound morbidity.
Conclusion: This is the first European and American guideline on the treatment of umbilical and
epigastric hernias. It is recommended that symptomatic umbilical and epigastric hernias are repaired
by an open approach with a preperitoneal flat mesh.
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Introduction
Umbilical and epigastric hernia repairs are frequently per-
formed surgical procedures with an expected low complica-
tion rate of 3⋅5 per cent1. The optimal repair method with
the best short- and long-term outcomes remains debat-
able. The choices are many. For instance, is it necessary to
use a mesh and, in the case of mesh repair, is a preformed
patch better than a flat mesh, and in which anatomical layer
should it be placed? Furthermore, when is a laparoscopic
approach preferable to an open approach?
In recent decades, the European Hernia Society (EHS)
has facilitated the creation of a number of guidelines
on the treatment and prevention of hernias, aiming at
improving and standardizing hernia care2,3. The Interna-
tional Endohernia Society (IEHS)4–6 published guidelines
on laparoscopic treatment of both primary ventral and
incisional hernias in 2014, but did not address open ventral
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hernia repair. The Society of American Gastrointestinal
Endoscopic Surgeons (SAGES)7 published a guide-
line on laparoscopic ventral hernia repair in 2016. An
expert-guided consensus for the management of all types
of ventral hernias exists8, and the World Society of Emer-
gency Surgery (WSES)9 addressed emergency repairs of
both primary ventral and incisional hernias. To date, no
guideline has been published on the treatment of umbilical
and epigastric hernias, specifically addressing both open
and laparoscopic techniques.
The aim was to develop guidelines for the treatment
of umbilical and epigastric hernias using watchful waiting
or any surgical technique. The guideline group included
surgeons from Europe and North America, thus including




The project was approved by the EHS and AHS boards in
February 2017. Two coordinators were appointed to man-
age the project. The guideline was intended for surgeons,
general practitioners and patients. A list of the members
of the group and their responsibilities is available in the
acknowledgements. Conflicts of interest (COI) for each
member were recorded transparently. The meetings were
funded by the EHS and AHS. There was no involvement
from industry.
Timeline and meetings
The protocol, including key questions and timeline, was
approved by eight participants at the AHS/EHS congress
in Miami, March 2018. A second meeting was held in
Amsterdam, September 2018, with 11 participants. Each
team presented their systematic review of the literature
for each subject, and draft recommendations were pro-
posed. Key questions needing further work were identified
and discussed at the third meeting in Malmö, February
2019, with nine participants. All suggested recommenda-
tions were discussed, some reformulated and thereafter
approved. The remaining three participants approved the
recommendations by e-mail. All members participated in
at least two of the three meetings.
Methodology
The Grading of Recommendations Assessment,
Development and Evaluation (GRADE) approach was
used in formulating the recommendations. The Scottish
Intercollegiate Guidelines Network (SIGN) critical
appraisal checklists were used for evaluation of the quality
of full-text papers. Key questions were proposed by the
coordinators, revised and thereafter approved by the group.
The group was divided into teams (2–3 members per
team) working on specific key questions. Each team
decided on important outcomes of key questions using
the PICO (patient, intervention, comparator, outcome)
approach. A systematic literature review was performed for
each key question. If up-to-date high-quality meta-analyses
or systematic reviews on the subject were available, the
conclusions were derived from these. Next level in quality
were RCTs and thereafter observational studies. Case series
were included only if they added substantial evidence/
information, or if no higher level of evidence was avail-
able. Case reports and expert opinions were not included.
The Appraisal of Guidelines for Research and Evaluation
(AGREE) instrument was followed.
The guideline was published in two parts. The current
guideline addressing the most common considerations on
the treatment of umbilical and epigastric hernias, and a
second guideline addressing umbilical and epigastric her-
nias in rare circumstances as wel as Spigelian and lumbar
hernias10. The guideline was presented at the EHS meet-
ing in September 2019, where consensus voting on selected
recommendations took place.
Literature search
A systematic literature search was performed by two
reviewers independently and reported on 1 May 2018,
and updated on 1 February 2019. The Cochrane Library,
PubMed, Embase, CINAHL and Google Scholar were
searched using Medical Subject Headings (MeSH) terms.
Search terms for each subject are available in Appendix
S1 (supporting information) together with PRISMA flow
charts (Figs S1–S5, supporting information). Records
were screened by title and abstract by two assessors. Full
texts were evaluated by two assessors independently. Only
papers rated as acceptable or high quality according to the
SIGN checklist were included, to limit the risk of bias. Any
disagreement between assessors was settled by discussion
either in the entire group or by a third assessor.
As data on primary ventral hernias were sparse, papers
concerning both primary ventral and incisional hernias
were included. Authors were contacted for extraction of
data on primary ventral hernias specifically. If this was not
possible, the paper was still included, but it was specified in
the text that data were derived from both primary ventral
and incisional hernias.
Results
Eighteen key questions (KQs) were formulated and a total
of 114 studies were finally included (Fig. 1).
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KQ 1: What is the definition of an umbilical hernia
and an epigastric hernia?
Statement: There is no available classification that clas-
sifies sizes of umbilical and epigastric hernias satisfacto-
rily. An umbilical hernia is defined as a primary hernia
with the defect located in the midline in the centre of
the umbilical ring. An epigastric hernia is defined as a
hernia with the centre of the defect in the midline above
the umbilicus up to the xiphoid process. The guide-
line group classified umbilical and epigastric hernias into
small (0–1 cm), medium (more than 1 cm up to 4 cm) and
large (over 4 cm) based on defect diameter.
Recommendation: It is suggested that a new consensus
on definition and size classification of umbilical and
epigastric hernias is created.
Quality of evidence:
Strength of recommendation: Weak
Umbilical hernias are common; asymptomatic hernias
may be present in up to 25 per cent of the population
when examined by ultrasound imaging11. In a nationwide
register-based study12 from Denmark, the prevalence of
an umbilical or epigastric hernia repair in a 5-year interval
showed a bimodal distribution. The overall number of
umbilical hernia repairs is higher in men than women. The
age-specific prevalence was observed to peak in early child-
hood (0–5 years) for both sexes, in older age (61–70 years)
for men, and in middle age for women (31–40 years). The
number of repairs for epigastric hernias was similar for
both sexes, with the age-specific prevalence peaking at
51–70 years for men and 41–50 years for women.
Studies specifically addressing risk factors for the
development of umbilical/epigastric hernias are lacking.
Connective tissue disorders, colonic diverticular disease,
obesity, presence of ascites, pregnancy, rectus diastasis,
native African and American ethnicity, and syndromes like
Down’s and Beckwith–Wiedemann have been suggested
as potential risk factors13–15.
The current classification system for both primary ven-
tral and incisional hernias was published in 2009 by the
EHS16, based on a consensus discussion of hernia special-
ists. This classification is based on both defect location
and size. As primary hernias in the midline usually have a
defect that is more or less round or oval-shaped, the size
was described with one measurement being the diameter of
the defect. Sizes were divided into small (0–2 cm), medium
(more than 2 up to 4 cm) and large (over 4 cm). The exact
definition of umbilical and epigastric hernias was not clear
in that publication. In 2012, another paper was published
on the development of the European registry for abdominal
© 2020 BJS Society Ltd www.bjs.co.uk BJS 2020; 107: 171–190
Published by John Wiley & Sons Ltd
174 N. A. Henriksen, A. Montgomery, R. Kaufmann, F. Berrevoet, B. East, J. Fischer et al.






A, epigastric hernia; B, umbilical hernia; 1, xiphoid process; 2, linea
alba – midline; 3, linea semilunaris (artist: Y. Renard).
wall hernias (EuraHS) from the EHS17. Here, an umbilical
hernia was defined as a primary hernia with its centre at
the umbilicus, and an epigastric hernia as a primary hernia
with its centre close to the midline above the umbilicus.
The guideline group discussed the definition of umbil-
ical and epigastric hernias thoroughly. The size division
into small, medium and large does not match the treatment
choices based on recent research, so it was decided to cre-
ate a new size classification. The guideline group defined
umbilical hernia as a primary hernia with the defect located
in the midline within the umbilical ring. An epigastric
hernia is defined as a primary hernia with the centre of the
defect located in the midline above the umbilicus up to the
xiphoid process (Fig. 2). The guideline group decided to
divide umbilical and epigastric hernias into small (0–1 cm),
medium (more than 1 cm up to 4 cm) and large (over 4 cm)
based on defect diameter.
KQ 2: Are diagnostic modalities indicated in the
management of umbilical and epigastric hernias?
Statement: Studies specifically designed to evaluate
diagnostic modalities for primary ventral hernias are
lacking. Umbilical and epigastric hernias are typically
diagnosed by clinical examination only. Imaging by ultra-
sound examination or CT can be considered if clinical
examination is inconclusive.
Recommendation: It is recommended that umbilical or
epigastric hernias are diagnosed by clinical examination
alone. Imaging by ultrasound examination or CT can be
considered in case of doubt.
Quality of evidence:
Strength of recommendation: Strong (upgraded)
In most patients, an umbilical or epigastric hernia can
be diagnosed by clinical examination alone. Only one case
series18 was identified that looked specifically at imaging
modalities, which found that ultrasound imaging is useful
if there is doubt on clinical examination. In general, diag-
nostic tests that may be used include ultrasound imaging,
CT, MRI, plain radiography and herniography. Additional
imaging has been reported to increase the accuracy of the
diagnosis to over 97 per cent19. Furthermore, one study20
reported that there is only a moderate correlation between
clinical examination, CT and intraoperative laparoscopic
assessment when measuring defect sizes in ventral hernias.
Preoperative imaging may be necessary in patients with
abdominal pain without a palpable hernia, or in obese
patients for measurement of the defect size when planning
the surgical approach.
Based on the limited evidence, it is not possible to make a
recommendation on any diagnostic approach. The guide-
line group suggested diagnosing umbilical or epigastric
hernias by clinical examination alone. Imaging by ultra-
sound examination or CT can be considered if the diag-
nosis is in doubt.
KQ 3: Is a watchful waiting strategy safe in patients
with asymptomatic umbilical or epigastric hernias?
Statement: There are limited data on watchful waiting
for patients with umbilical and epigastric hernias, but a
watchful waiting strategy seems safe.
Recommendation: For asymptomatic umbilical and
epigastric hernias, a watchful waiting strategy can be
suggested.
Quality of evidence:
Strength of recommendation: Weak
Only one study21 has evaluated the safety of watchful
waiting in patients with ventral hernias. A total of 1358
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ventral hernias, including incisional, umbilical and epigas-
tric defects, were evaluated. Watchful waiting was defined
as non-operative management. It appears safe, even though
up to 19 per cent of the patients may undergo surgery at
a later point. Data specifically on umbilical and epigastric
hernias were not available. In a small prospective observa-
tional study22 of 25 patients in whom non-operative treat-
ment of a primary ventral hernia was planned, and who
were followed for a median of 12 months, 20 and 4 per cent
underwent elective and emergency repair respectively.
Data are lacking on the prevalence of umbilical and
epigastric hernias in general and on the number of patients
undergoing hernia repair. The guideline group suggested
a watchful waiting strategy for asymptomatic umbilical and
epigastric hernias.
Optimization for surgery
KQ 4: Is optimization of the patient necessary before
elective umbilical or epigastric hernia repair?
Statement: Wound complications are the most com-
mon complication in ventral hernia repair. Smoking and
obesity increase the risk of postoperative wound com-
plications in general, but data are limited considering
umbilical and epigastric hernia repair specifically. From
other types of surgery, it is known that 4 weeks of smok-
ing cessation before surgery, and weight loss for obese
patients, reduce the risk of surgical-site infection.
Recommendation: It is suggested to advise smoking
cessation for 4–6 weeks, and weight loss to BMI below
35 kg/m2, before elective umbilical or epigastric hernia
repair.
Quality of evidence:
Strength of recommendation: Weak
The literature on complications after primary ventral her-
nia repair is limited. Only two large cohort studies1,23,
both with data from the Danish Hernia Database, were
identified. A total of 6783 umbilical and epigastric her-
nia repairs were included. The overall readmission rate
was 5⋅9 per cent. Reasons were: wound infection (36⋅8 per
cent), pain (30⋅6 per cent) and haematoma (16⋅5 per cent)1.
Patients undergoing recurrent hernia repair had a signif-
icantly higher risk of readmission for either a surgical or
medical complication, compared with patients undergoing
primary hernia repair (7⋅4 and 4⋅9 per cent respectively;
P = 0⋅026). The 30-day reoperation and mortality rates
were 0⋅3 and 0⋅2 per cent respectively1. No data were avail-
able on smoking, BMI or patient co-morbidity1.
In a large cohort study24 from the American College
of Surgeons National Surgical Quality Improvement
Project of more than 220 000 patients, including inguinal,
umbilical and incisional hernia repairs, smoking was
associated with increased readmissions and reoperations24.
Small retrospective studies have looked at risk factors
for recurrence after primary ventral hernia repair. Four
small case series25–28 reported no association between obe-
sity and recurrence, whereas obesity was reported to be
an independent risk factor for recurrence in two other
studies29,30. Wound infection after primary repair may be
associated with an increased recurrence rate29,31, but other
studies27,28,32 could not confirm this finding.
In an expert consensus report8 on elective surgical man-
agement of both primary ventral and incisional hernias, it
was suggested that patients should quit smoking and lose
weight if their BMI exceeded 30 kg/m2.
The most frequent complications after umbilical and epi-
gastric hernia repair are wound complications1. Smoking
and obesity are known to be associated with increased
wound morbidity in general33, but there are no clear data
on whether smoking or obesity is related to a poorer
postoperative outcome after umbilical or epigastric hernia
repair. No recommendation can therefore be made based
on the available literature, but the guideline group sug-
gested that smoking cessation and weight loss to BMI less
than 35 kg/m2 is advised before elective hernia repair.
KQ 5: Is antibiotic prophylaxis indicated for umbili-
cal and epigastric hernia repair?
Statement: There is insufficient evidence to recommend
routine use of antibiotic prophylaxis in umbilical and epi-
gastric hernia repair to decrease the rate of surgical-site
infection. However, surgical-site infection is a significant
complication of umbilical and epigastric hernia repair,
especially when mesh is inserted; in this situation antibi-
otic prophylaxis may be useful.
Recommendation: Prophylactic antibiotics, given as a
single perioperative dose, is suggested when a mesh is
used for umbilical or epigastric hernia repair.
Quality of evidence:
Strength of recommendation: Weak
In 2016, the WHO34 published guidelines on the preven-
tion of surgical-site infection after surgery. These guide-
lines included a list of 29 concrete recommendations
distilled by leading experts reviewing the latest evidence.
However, these recommendations were not specifically
aimed at hernia surgery, and did not address perioperative
antibiotic prophylaxis. Nevertheless, it was recommended
that antibiotic prophylaxis should not be prolonged after
completion of surgery.
Literature on the use of perioperative antibiotics for
elective primary ventral hernia repair is limited. One
meta-analysis35 on antibiotic prophylaxis for abdominal
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wall hernia repair in general was identified, which con-
cluded that further studies are needed on ventral hernia
repair. This meta-analysis included one small RCT36 of 19
patients scheduled for umbilical hernia repair and random-
ized to preoperative antibiotics or not. One of nine patients
in the antibiotics group had postoperative wound infection
compared with four of ten in the control group (P = 0⋅3).
A sample size of 19 patients is extremely small, so the study
is of limited value. The IEHS6 and SAGES7 guidelines for
laparoscopic ventral hernia repair both recommend a single
dose of second-generation cephalosporin for ventral hernia
repair.
It is known that postoperative wound infection is a sig-
nificant complication in umbilical and epigastric hernia
repair1. Previous guidelines for laparoscopic repair of all
types of ventral hernia recommend antibiotic prophylaxis.
Wound infection rates may be higher for open repairs than
for laparoscopic repairs. All included literature was pub-
lished before the WHO guideline34 on the prevention of
surgical-site infection, which is why it is likely that not
all recommendations from the WHO guidelines were fol-
lowed. Data are limited for umbilical and epigastric hernia
repair specifically, but the guidelines group suggests that
prophylactic antibiotics are given as a single perioperative
dose for both laparoscopic and open repair when a mesh
is used. The type of antibiotic is chosen according to local
protocol.
Surgical considerations
KQ 6: Is there a place for sutured repair in elective
umbilical or epigastric hernia repair?
Statement: The use of mesh for open umbilical or
epigastric hernia repair reduces the rate of recurrence
without increasing the rate of surgical-site infection or
postoperative pain. The quality of evidence is limited for
hernias with defect sizes smaller than 1 cm.
Recommendation: It is recommended that mesh is used
for repair of umbilical and epigastric hernias to reduce
the recurrence rate. Sutured repair can be considered in
shared decision-making and for small hernia defects of
less than 1 cm.
Quality of evidence:
Strength of recommendation: Strong
Repair of umbilical and epigastric hernias can be achieved
with both suture and mesh repair. The recurrence rate
after sutured umbilical hernia repair varies between 1 and
54⋅5 per cent, depending on the follow-up method25,37–39.
A large cohort study40 of 1313 patients having a suture
or mesh repair of an umbilical or epigastric hernia with
a defect smaller than 2 cm reported an overall recurrence
rate of 14 per cent after median of 3 years. Until recently,
studies evaluating the use of mesh for smaller umbilical
and epigastric hernias were limited. In the past decade, five
meta-analyses41–45 evaluating the use of mesh for umbilical
and epigastric hernias have been published. All concluded
that mesh is superior to sutures in terms of decreasing
recurrence. The most recent high-quality meta-analysis44
included data from RCTs37,38,46–48, retrospective cohort
studies26,49–51 prospective observational studies25,31 and
studies from hernia registries40,52,53. All found that the
recurrence rate decreased with the use of mesh com-
pared with sutures, without increasing surgical-site infec-
tions, seroma, haematoma or chronic pain. However, in
a large database study1 of umbilical and epigastric her-
nias, the use of mesh was associated with increased read-
mission rates1. In a recent RCT48 comparing mesh versus
suture repair of umbilical hernia, a secondary outcome was
patient-reported preoperative and postoperative quality of
life. Patients did not report any difference in either the
Short Form 36 or five-level EuroQoL Five Dimensions
(EuroQoL Group, Rotterdam, the Netherlands) question-
naire between the two techniques. No other studies were
identified that compared patient-reported outcomes after
sutured or mesh repair.
Evidence is limited for hernia defects smaller than 1 cm. A
subgroup analysis of a meta-analysis44 suggested that mesh
is also beneficial for small defects, in decreasing recurrence
rates. More evidence is needed concerning the role and
optimal placement of mesh in patients with an umbilical
hernia smaller than 1 cm44.
The use of mesh reduces recurrence without significantly
increasing the rate of surgical-site infection or postopera-
tive pain; therefore, it is recommended that mesh is used for
umbilical and epigastric hernia repairs. For defects smaller
than 1 cm the evidence is limited, and a sutured repair may
be considered in shared decision-making with the patient.
KQ 7: Which is the preferred technique for sutured
repair of umbilical or epigastric hernias?
Statement: There is insufficient evidence to recom-
mend the use of a specific type of suture or sutur-
ing technique for sutured repair of umbilical or epigas-
tric hernias. Studies indicated that slowly resorbable or
non-absorbable sutures were used most commonly.
Recommendation: It is suggested that slowly resorbable
or non-absorbable sutures are used for sutured repair of
umbilical and epigastric hernias. The suture technique
can be chosen by the surgeon. It is recommended not to
use quickly absorbable sutures.
Quality of evidence:
Strength of recommendation: Weak
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Suture type (non-absorbable, slowly absorbable or
quickly absorbable) and technique (continuous or inter-
rupted) may play a role in reducing the risk of recurrence.
Special techniques named after surgeons such as Mayo54
have also been described.
Two large studies40,52 from the Danish Hernia Database
compared non-absorbable (most patients), slowly
absorbable and quickly absorbable sutures after a median of
21–43 months’ follow-up, and found no difference in the
cumulative recurrence rate between suture types. There
were no studies evaluating the role of antibiotic-coated
sutures in primary ventral hernia repair.
In the non-mesh group of cohort studies and RCTs
(mesh versus suture) for umbilical and epigastric hernias,
interrupted non-absorbable sutures were used in most
studies37,38,46,48–50,55. Type of suture was not specified in
two studies25,31.
In two RCTs38,55 and two case series25,50, the tech-
nique was further specified as the Keel technique55 (defect
sutured in 2 layers) or Mayo technique (double-breasted
sutures)25,38,50. Dalenbäck and colleagues50 reported no
difference in recurrence between use of double-row sutures
(8⋅2 per cent), single-row sutures (4⋅7 per cent) or Mayo
repair (5⋅3 per cent). In the study by Kaufmann and
co-workers48, continuous or simple interrupted sutures
were used (surgeon’s choice), and there was no difference
in recurrence rates between the techniques.
There is insufficient evidence to recommend the use of
a specific type of suture or suturing technique for repair
of umbilical or epigastric hernias. The guideline group
suggested using a non-absorbable or slowly absorbable
suture, and the technique chosen by the surgeon.
KQ 8: Which is the optimal surgical approach for an
acutely strangulated/incarcerated umbilical or epi-
gastric hernia?
Statement: Emergency hernia repairs are heteroge-
neous. Many patient-related factors play a role in poten-
tial morbidity and mortality. There is low-level evidence
to suggest that the use of non-resorbable mesh is safe
for strangulated/incarcerated umbilical or epigastric her-
nia repair. Mesh can be used in patients with a clean or
clean-contaminated surgical field.
Recommendation: It is suggested that the emergency
repair of umbilical or epigastric hernias should be tai-
lored to patient and hernia characteristics. The use of
mesh can be considered.
Quality of evidence:
Strength of recommendation: Weak
An emergency procedure is associated with worse out-
comes than elective surgery. These differences are largely
related to patient co-morbidity rather than the emergency
nature of the procedure56. Data from the Danish Her-
nia Database1 suggest that emergency repair of an umbil-
ical or epigastric hernia is associated with up to 15-fold
higher mortality, reoperation and readmission rates. In the
USA, the incidence of urgent hernia repairs has increased
slightly during the past decade, with the greatest increase in
patients aged over 65 years. For umbilical hernias, the inci-
dence per 100 000 person-years reached its highest rate in
2009 (11⋅7 per cent)57.
It has been suggested that the use of a mesh repair for
incarcerated umbilical hernia is safe55,58. The presence of
non-viable intestine should not be regarded as a contraindi-
cation to mesh repair55. Wound infection rates are higher
after emergency hernia repair, but clinical consequences
are relatively rare59. No studies were identified on the use
of biological mesh in emergency repair of umbilical or epi-
gastric hernias.
In the WSES guideline9 for emergency repair of hernias,
it is recommended that synthetic mesh is used in clean or
clean-contaminated procedures. In a contaminated field, a
primary sutured repair is suggested for defects smaller than
3 cm; alternatively, biological mesh may be considered9. In
this guideline, ventral hernias included both primary and
incisional hernias.
Sepsis and co-morbidity play a role in the morbidity and
mortality of emergency repair. There is low-quality evi-
dence indicating that the use of a non-resorbable mesh
in a clean or clean-contaminated emergency hernia repair
is safe. Based on this, the guideline group suggested tai-
loring the repair based on patient and hernia charac-
teristics. A non-resorbable mesh can be used in both
clean and clean-contaminated procedures. The guideline
group suggested placing the mesh outside the peritoneal
cavity.
Open hernia repair of umbilical and epigastric
hernias with mesh
KQ 9: Which is the preferred type of mesh, and the
preferred layer for mesh placement when doing an
open umbilical or epigastric hernia repair?
Statement: The use of intraperitoneal preformed
patches for umbilical or epigastric hernia repairs may
shorten operating time, but may be associated with
increased complication rates compared with placing a
flat mesh in the preperitoneal space. Patches or pre-
shaped prosthetics with antiadhesive barriers are more
expensive than a synthetic flat mesh. There is acceptable
evidence that placement of mesh in the retromuscular or
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preperitoneal position is associated with a lower rate of
surgical-site infection and recurrence. Placement of the
mesh in the preperitoneal space seems safe and feasible.
Recommendation: It is suggested that a flat permanent
mesh is placed in the preperitoneal space for open umbil-
ical or epigastric hernia repair.
Quality of evidence:
Strength of recommendation: Weak
There is acceptable evidence that umbilical and epigastric
hernias can be repaired safely using a synthetic polypropy-
lene mesh30,37,48,60,61. Similar to incisional hernias, there
are five theoretical anatomical layers for mesh placement:
onlay, in the prefascial plane above the linea alba; fixing
the mesh to the borders of the repair (inlay plug); retro-
muscular, between the rectus muscle and the posterior
rectus sheath; preperitoneal, between the posterior rectus
sheath and the peritoneum; and intraperitoneal, also called
intraperitoneal onlay mesh (IPOM)62,63.
The number of preformed meshes, plugs and prosthetics
for repair of umbilical and epigastric defects is increasing.
Although the use of these prosthetics may shorten oper-
ating time64–66 and reduce postoperative pain38, there is
no evidence to support their use instead of a conventional
flat synthetic mesh. Most of these prosthetics are manufac-
tured to allow their use in the intraperitoneal position with
an antiadhesive barrier. There are a number of case series
on their safety51,64,66–69. Concerns have arisen from a few
reports of severe late complications, such as bowel obstruc-
tion, explantation owing to infection and enterocutaneous
fistula formation69–71. For this reason, preperitoneal place-
ment of a preformed patch should be considered, when
possible72.
To date, only one RCT (mesh versus patch repair for
epigastric and umbilical hernia, MORPHEUS)64 has
compared an intraperitoneal patch with a preperitoneal
low-weight polypropylene flat mesh. Surgery was easier
and slightly quicker with an intraperitoneal patch and the
early reoperation rate owing to serious complications was
significantly higher in the intraperitoneal patch group.
The complication rate was higher in the patch group than
in the flat mesh group at 2-year follow-up (32⋅5 versus
22⋅1 per cent; P = 0⋅044). There was no difference in
recurrence rate65. The cost of a patch is higher than that
of a flat mesh. Nevertheless, this study evaluated only one
specific type of patch; there are many different patches on
the market.
One small prospective cohort study73 evaluated the use
of a biological mesh for primary umbilical hernia repair
in 36 patients, and concluded that it seemed to be safe
and reliable, with a high degree of patient comfort. As this
is the only available study, with preliminary results and
no control group, the use of biological mesh cannot be
supported on this basis. There are no studies comparing
the use of polyester, polyvinylidene fluoride or absorbable
meshes, and there are no data comparing the efficacy and
safety of meshes of different porosity or density used in
open repairs.
Data from the AHS database (AHS quality
collaborative)74 showed no difference in 30-day morbidity
between matched sublay (pooling retromuscular, preperi-
toneal and intraperitoneal) and onlay repairs of primary
ventral and incisional hernias. Two meta-analyses75,76,
also including both primary ventral and incisional hernias,
found that retromuscular mesh placement had the low-
est probability of surgical-site infection and recurrence.
However, these results cannot be extrapolated to primary
ventral hernias alone.
A cohort study52 from the Danish Hernia Database,
including 4786 patients who had an umbilical or epigas-
tric hernia repair, found no difference in reoperation rate
between different mesh positions, except that use of an
inlay plug had a higher recurrence rate. A recent RCT48
comparing suture repair with mesh repair of 1–4-cm
umbilical hernias found that preperitoneal flat mesh had
a lower recurrence rate (4 per cent versus 12 per cent for
suture repair), without an increase in complications.
Even though data are sparse, there may be more serious
complications associated with the use of intraperitoneal
patches and a higher rate of reoperations. Based on this,
together with a higher cost of patches, the guideline group
suggested placing a conventional flat permanent mesh in
the preperitoneal space.
KQ 10: Which is the preferred mesh overlap for open
umbilical or epigastric hernia repair?
Statement: There is not enough evidence to recom-
mend a specific mesh overlap that may reduce recurrence
after umbilical and epigastric hernia repair. A preperi-
toneal mesh with an overlap of 3 cm has been associated
with low recurrence rates in umbilical hernia repairs with
defects of 1–4 cm.
Recommendation: In preperitoneal mesh repair for
open umbilical and epigastric hernia repair, an overlap
of 3 cm is suggested for defects of 1–4 cm.
Quality of evidence:
Strength of recommendation: Weak
In a systematic literature review77 including both open
and laparoscopic primary ventral and incisional hernia
repairs, it was concluded that there was no significant asso-
ciation between hernia recurrence and mesh overlap for
© 2020 BJS Society Ltd www.bjs.co.uk BJS 2020; 107: 171–190
Published by John Wiley & Sons Ltd
Guidelines for treatment of umbilical and epigastric hernias 179
open repairs. In a prospective case series66 that used an
intraperitoneal patch, there were no differences in mesh
overlap between recurrent and non-recurrent hernias. In
a recent retrospective study78 of 1558 patients with a mean
follow-up of 4 years, an overlap of less than 1 cm was asso-
ciated with a higher recurrence rate in univariable analysis.
In two recent RCTs48,64, use of a mesh overlap of 3 cm was
associated with low recurrence rates. For defects less than
1 cm, a smaller mesh overlap may be sufficient, but there
are currently no data available. Based on this, it seems rea-
sonable to suggest a 3-cm mesh overlap for open primary
ventral hernia repairs with defects of 1–4 cm.
KQ 11: Which is the preferred method of mesh fix-
ation for open umbilical or epigastric hernia repair?
Statement: There is not enough evidence to recom-
mend any method of fixation over another, where to fix
the mesh, or whether mesh fixation is even necessary in
open umbilical or epigastric hernia repair. Most studies
described suture fixation with non-absorbable sutures.
Recommendation: If the mesh is fixed for an umbil-
ical or epigastric hernia repair, it is suggested that a
non-absorbable suture is used.
Quality of evidence:
Strength of recommendation: Weak
There are no studies comparing different fixation tech-
niques or types of suture to fix the mesh in open repair of
primary ventral hernias. In two high-quality RCTs48,64 of
open mesh repair of umbilical hernias, a non-absorbable
suture was used for mesh fixation. The guideline group
discussed whether mesh fixation was always necessary,
and many agreed that it may not be necessary when
preperitoneal mesh placement is used. However, there is
no literature addressing this issue. If the mesh is fixed, the
guideline group suggested using a non-absorbable suture
for mesh fixation.
KQ 12: Should the defect be closed for open umbil-
ical and epigastric hernia repairs when a mesh is
used?
Statement: There is not enough evidence to recom-
mend whether the defect should be left open or closed
in open primary ventral hernia repair. Studies using a flat
mesh have reported closing the defect.
Recommendation: When performing umbilical or epi-
gastric hernia repair and a flat mesh is used, it is suggested
that the defect is closed.
Quality of evidence:
Strength of recommendation: Weak
There are no studies on primary ventral hernias focusing
specifically on defect closure. When mesh plug inlay
techniques or preformed patches are used, the defect may
not be closed as the mesh is fixed to the border of the
defect38,70. When preperitoneal flat mesh or an onlay mesh
is used, the fascial defect is usually closed48,74. In the
MORPHEUS trial65, patients with umbilical hernia were
randomized to preperitoneal flat mesh or intraperitoneal
patch; the fascia was closed in 86 per cent of patients.
It is unknown whether closing the defect influences the
outcome of the repair. However, there is a growing ten-
dency towards restoration of the midline. When mesh is
placed in the preperitoneal plane, closure of the defect pre-
vents the mesh entering the subcutaneous space. Based on
the available sparse data, it is suggested that the defect is
closed with a slowly absorbable or non-absorbable suture.
KQ 13: Which is the preferred anaesthetic method
for open umbilical and epigastric hernia repair?
Statement: Available evidence shows that local anaes-
thesia can be used safely for open umbilical and epigastric
hernia repairs. There is no evidence to support the supe-
riority of local anaesthesia over general anaesthesia.
Recommendation: The guideline group suggests
adhering to local protocols, and that the patient, sur-
geon and anaesthetist agree on the type of anaesthesia
for open umbilical or epigastric hernia repair based on
shared decision-making.
Quality of evidence:
Strength of recommendation: Weak
In a systematic review of available evidence, the use
of local anaesthesia led to a shorter postoperative stay
compared with general anaesthesia79. The use of local
anaesthesia did not lead to serious perioperative compli-
cations, allergic responses or anaesthesia-related deaths80.
There is no consensus regarding the type of anaesthetic
drug or technique used for local anaesthesia. Local anaes-
thesia for umbilical hernia repair seems safe and feasible.
There is no literature on potential advantages of using
local rather than general anaesthesia. Based on this, no
recommendation is given on method of anaesthesia. The
guideline group suggested adhering to local protocols,
and that the patient and surgeon agree on the type of
anaesthesia based on shared decision-making.
Laparoscopic repairs of umbilical and epigastric
hernias
KQ 14: What are the indications for laparoscopic
umbilical and epigastric hernia repair?
Statement: Laparoscopic repair decreases the risk of
wound complications. It may be beneficial for large (over
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4 cm) umbilical or epigastric hernias. For medium-sized
hernias, laparoscopic repair may be considered in
patients at high risk of wound infection.
Recommendation: It is suggested that laparoscopic
repair is considered for large umbilical or epigastric her-
nias, or if the patient has an increased risk of wound
infection.
Quality of evidence:
Strength of recommendation: Weak
One systematic review and meta-analyses81 compared
laparoscopic and open repair of umbilical hernias. It
included three RCTs and seven retrospective cohort
studies with a total of 16 549 patients. Open repair was
associated with a higher risk of wound infection, wound
dehiscence, recurrence, increased duration of hospital
stay, but shorter operating times than laparoscopic repair.
Six other meta-analysis and systematic reviews82–87 com-
pared the effectiveness of laparoscopic and open repair,
but included both primary ventral and incisional hernias.
These studies showed no differences in recurrence rates,
seroma risk, duration of operation or postoperative pain
between techniques, but with conflicting data and low
levels of evidence. Laparoscopic repair had a significantly
lower rate of wound infections and shorter hospital stay
than open repair, but laparoscopic repair was associ-
ated with a slightly higher rate of perioperative bowel
injury86,87. The results of these meta-analyses should be
interpreted with caution because techniques, mesh types,
mesh position and fixation methods differed greatly. No
distinction was made between umbilical, epigastric or
incisional hernia.
Laparoscopic ventral hernia repair is associated with
a decreased risk of surgical-site infection. Larger defect
sizes and obesity may be associated with an increased risk
of wound complication following open hernia repair29,30.
Based on this, it is suggested that laparoscopic repair is con-
sidered for large (over 4 cm) umbilical or epigastric hernias,
or if the patient has an increased risk of wound infection.
KQ 15: What is the preferred laparoendoscopic
repair method for umbilical or epigastric hernias?
Statement: Novel laparoscopic and endoscopic tech-
niques, including robot-assisted techniques with
extraperitoneal mesh placement, seem promising,
with theoretical advantages over the traditional IPOM
technique. There are insufficient data to suggest one
technique over another for repair of umbilical or
epigastric hernias. As an intraperitoneal mesh may cause
adhesions, placement of the mesh in the preperitoneal
or retromuscular position is suggested, when possible.
Closure of the hernia defect seems to decrease seroma
formation, bulging and recurrence. A mesh overlap of
at least 5 cm seems to decrease recurrence rates. For
IPOM repairs, fixation of the mesh using non-absorbable
sutures or tacks decreases the recurrence rate.
Recommendation: For laparoscopic umbilical or epi-
gastric hernia repairs, it is suggested that the defect is
closed when possible, and the mesh is placed in the
preperitoneal or retromuscular position with an overlap
of at least 5 cm. It is suggested that an intraperitoneal
mesh is fixed with non-absorbable sutures or tacks.
Quality of evidence:
Strength of recommendation: Weak
The initial description of the laparoscopic technique for
ventral hernia repair used IPOM88. This is now the most
used technique. There has been concern about the risk of
adhesions related to the intraperitoneal mesh. In a series
of 733 patients undergoing laparoscopic IPOM, 2 per cent
had reoperation for bowel obstruction, and 2 per cent for
mesh infection after a mean follow-up of 19 months89.
The robotic technique has reinvigorated interest
in the potential for extraperitoneal mesh placement
(retromuscular or preperitoneal)90. Furthermore,
endoscopic/mini-open sublay (eMILOS) repair, the totally
extraperitoneal (eTEP) approach and totally endoscopic
sublay repair are new endoscopic techniques that avoid
intraperitoneal mesh placement91–93. Case series92,94,95
report low complication and recurrence rates. eMILOS,
eTEP and robotic surgery seem promising, with theoreti-
cal advantages over the traditional IPOM technique96–99.
There are currently insufficient data to suggest the
superiority of one technique over another.
The classical IPOM repair included fixation of the mesh
that bridged the defect. The durability of the repair
depended on the strength of fixation100. Protrusion or
bulging of the non-closed defect can occur, which can
mimic recurrence, and has a reported incidence of up
to 31⋅5 per cent42,101–103. Furthermore, the bridge tech-
nique may have high rates of seroma, infection and patient
dissatisfaction42,102,103. Laparoscopic defect closure, some-
times referred to as ‘IPOM plus’, attempts to recreate a
normal, functional dynamic anatomy by re-approximating
the abdominal wall under tension, which may restore func-
tion and prevent bulging42,102,103.
One high-quality meta-analysis103 and a systematic
review42 of acceptable quality comparing closure with
non-closure of the gap reported decreased recurrence
and seroma rates in the closure group. The variability
in study quality, and inclusion of both primary ventral
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and incisional hernias, mean that conclusions must be
interpreted with caution. Four other studies101,104–106
have since been published, which included both primary
ventral and incisional hernia repairs. Two104,106 confirmed
the results of the review and meta-analyses, whereas the
other two101,105 did not show any difference in seroma
formation or surgical-site complications.
Closure of the defect may allow a wider lateral mesh over-
lap, which may further reduce the recurrence rate. There
is no convincing evidence for type of suture material or
technique for closing the defect in laparoscopic umbili-
cal hernia repair. In a systematic literature review77 of 95
articles, the risk of recurrence was decreased with increas-
ing mesh overlap for laparoscopic repairs, mainly without
defect closure. The lowest recurrence rate was found with a
mesh overlap of more than 5 cm. The IEHS guidelines4–6
recommend a mesh overlap of more than 3 to 4 cm in all
directions, and over 5 cm if the mesh is fixed without trans-
fascial sutures.
Another study107 evaluated 213 consecutive patients
undergoing laparoscopic repair of incisional and primary
ventral hernias, and reported that the mesh area to defect
ratio was the most important predictor of recurrence. A
mesh to defect ratio of 16 is the threshold above which the
risk of recurrence is almost zero107. In a physical model
mimicking a passive abdominal wall, it was reported that
defect size was the most important parameter regarding
stress of the mesh and overlap related to mesh stress108.
The mesh may be fixed by one of two main types of
device: sutures and tacks, alone or combined. Both can
be of absorbable or permanent material. Two systematic
reviews109,110 and four high-quality meta-analyses111–114
compared tacks versus sutures versus both for repairs
including primary ventral and incisional hernias. The four
meta-analyses all evaluated different studies and outcomes,
making comparisons difficult.
The two systematic reviews evaluated suture and tack
fixation. One109 reported a lower recurrence rate for the
sutured technique; the other110 could not confirm this
finding, but found more infections with sutures than tacks.
In a network meta-analysis113, there seemed to be an overall
advantage of combining tacks with sutures to decrease the
recurrence rate, compared with tacks alone.
In a comparison of non-absorbable tacks and
non-absorbable transfascial sutures, there were no
significant differences in the rates of chronic pain (lasting
more than 3 months), duration of stay, recurrence rate,
and seroma and haematoma occurrence. The operating
time was significantly lower when tacks were used, but
the cost of the devices was higher114. The finding of a
shorter operating time with tacks as opposed to sutures
was confirmed in another meta-analysis112 that also found
decreased postoperative pain in the suture group, with no
difference in recurrence rate and duration of hospital stay.
Comparing absorbable and non-absorbable tacks, there
were no differences in recurrence rate or chronic pain, but
operating time was longer in the absorbable tack group111.
One small RCT115 (40 patients) analysed the differ-
ence between titanium tacks and fibrin sealant, in a study
including 90 per cent primary ventral hernias (defect size
1⋅5–5 cm). Pain scores were significantly lower over the
first 10 days after surgery with use of glue, but there was
no difference between groups at 30 days. The recurrence
rate was 26 per cent after use of fibrin sealant versus 6 per
cent with tacks at 1-year follow-up116.
Only one study117 has reported on primary ventral her-
nias alone; non-absorbable tacks were compared with
absorbable tacks in a cohort study of 80 patients with an
umbilical hernia (defect size no larger than 2 cm). Early and
chronic pain were the only outcomes evaluated. Less pain
was reported in the absorbable tacks group until 12 weeks,
but not at follow-up of 18 months.
The literature is heterogeneous and does not specifi-
cally evaluate laparoscopic repairs of umbilical and epi-
gastric hernias. Recommendations should be applied with
care. Novel laparoscopic techniques with extraperitoneal
mesh seem promising, with theoretical advantages over
traditional IPOM techniques. There are currently insuffi-
cient data to suggest the superiority of one technique over
another. As an intraperitoneal mesh may cause adhesions,
extraperitoneal mesh placement is suggested, when possi-
ble. Closure of the defect seems to decrease seroma forma-
tion, bulging and recurrence, and should be attempted. For
laparoscopic repair, a mesh overlap of at least 5 cm appears
to decrease recurrence rates. For IPOM repairs, fixation of
the mesh with a non-absorbable device, either sutures or
tacks, decreases the recurrence rate.
Umbilical and epigastric hernia repair, tailoring the
approach
KQ 16: Which is the preferred repair method for
umbilical and epigastric hernias based on hernia and
patient characteristics?
Statement: Most umbilical and epigastric hernias can be
repaired with an open mesh repair. For larger defects,
or in patients with an increased risk of wound complica-
tions, laparoscopic repair or one of the novel endoscopic
techniques may be considered.
Recommendation: Although most umbilical and epi-
gastric hernias can be repaired with an open preperi-
toneal flat mesh, it is recommended that the repair is
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Fig. 3 Suggested algorithm for repair of symptomatic umbilical and epigastric hernias
Symptomatic umbilical or epigastric hernia







Preperitoneal flat mesh with 2-cm overlap
Non-absorbable or slowly absorbable suture
Preperitoneal flat mesh with 3-cm overlap
Preperitoneal or retromuscular mesh with 5-cm
overlap
Treat as an incisional hernia> 4 cm
> 1–4 cm
0–1 cm
Data on the optimal repair method are limited for small defects.
Mesh repair seems to decrease the risk of recurrence, but there
are no data on patient-reported outcomes. Open mesh repair or
sutured repair may be considered based on patient characteristics
and in shared decision-making with the patient
For medium-sized defects, use of mesh decreases the recurrence
rate significantly without increasing wound complications and
postoperative pain. An open approach with a flat mesh placed
preperitoneally, with an overlap of 3 cm, is suggested for the
majority of these. The laparoscopic approach may be considered
in patients with multiple defects or patients at high risk of wound
complications
Large umbilical and epigastric hernias are rare. It is suggested
that they are treated as incisional hernias. 
tailored based on patient and hernia characteristics and
local resources. Patient and surgeon preferences should
also be taken into account.
Quality of evidence:
Strength of recommendation: Strong (upgraded)
An algorithm for the repair of symptomatic umbilical and
epigastric hernias was constructed based on evaluation of
the literature and expert opinions in the guideline group
(Fig. 3).
The most common complication after umbilical and epi-
gastric hernia repair is wound morbidity. Obesity, smoking,
diabetes and immunosuppression are factors known to be
associated with wound complications in general, but evi-
dence is limited for umbilical and epigastric hernia repairs
specifically.
The majority of umbilical and epigastric hernias are small
or medium-sized, and an open repair with mesh reduces the
recurrence rate without increasing complications, although
data are limited for defects of 0–1 cm44. For all types of
ventral hernia, sublay mesh placement has been associ-
ated with the lowest risk of surgical-site infection and/or
recurrence75,76. Sublay placement includes the preperi-
toneal, retromuscular and intraperitoneal spaces. Owing to
the risk of intra-abdominal adhesions, it seems advanta-
geous to avoid intraperitoneal mesh placement. For small
umbilical and epigastric hernia repairs, it causes less trauma
to create a preperitoneal than a retromuscular space. Either
a flat mesh or a preformed patch may be used in the
preperitoneal space. Preformed patches are more expen-
sive and associated with a higher rate of postoperative
complications65.
Based on this, the use of a flat mesh placed in the preperi-
toneal space is suggested. To avoid mesh migration to the
subcutaneous space, it is suggested that the defect above
the mesh is closed. The optimal mesh size for small and
medium-sized umbilical and epigastric hernias has not been
studied but, for open repairs, a mesh overlap of 2 cm is sug-
gested for the smallest defects, and 3 cm for medium-sized
defects. For small (less than 1 cm) umbilical and epigas-
tric hernias, data concerning use of mesh are limited.
Although mesh seems to decrease recurrence, a sutured
repair may be considered in shared decision-making with
the patient. For medium-sized (more than 1 cm up to
4 cm) umbilical or epigastric hernias, an open approach
with a preperitoneal flat mesh is suggested. A laparoscopic
approach may be considered for repair of multiple defects
or in obese patients. Large umbilical and epigastric hernias
(over 4 cm) are rare, and should be treated as an incisional
hernia using mesh.
Learning curve and cost
KQ 17: What is the learning curve for umbilical and
epigastric hernia repair?
Statement: The evidence concerning any learning
curve for umbilical and epigastric hernia repairs is very
limited. The specific number necessary to perform
the procedure independently has not been assessed in
the literature. Standard programmes for hernia repair
including lectures and simulation training seem promis-
ing. The mentor plays an important role and should
be trained to provide structured teaching of important
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surgical steps. For laparoscopic ventral hernia repairs,
the complication and recurrence rates seem to decrease
after around 30 procedures.
Recommendation: The learning curve for open and
laparoscopic umbilical and epigastric hernia repair is sug-
gested to be around 20 and 30 supervised procedures
respectively. It is suggested that a standard training pro-
gramme should be offered to surgical trainees, with eval-
uation of when they can perform the procedures safely
and independently.
Quality of evidence:
Strength of recommendation: Weak
Training the next generations of surgeons is fundamental
to a sustainable healthcare system. Surgical training is
lengthy and costly. Open primary ventral hernia repair
is often one of the earliest procedures a surgical trainee
gets to perform. Day-care units offer an ideal setting for
structured education and training in standard techniques,
with attention to surgical details. The mentor plays an
important role and should be trained to provide structured
teaching. The impact of surgical training on quality of
operative outcomes should be limited to possibly longer
operations, and should not influence the quality of surgery
adversely.
Little has been published on the learning curve of pri-
mary ventral hernia repair. A retrospective study118 includ-
ing 508 open and laparoscopic umbilical hernia repairs
revealed that trainees took longer, but with no differences
in duration of stay or readmission rate compared with con-
sultants or specialists. Bowel injury is a serious complica-
tion in laparoscopic ventral hernia repair that is signifi-
cantly reduced after 25–32 operations119. The same trend
has been observed for recurrence, which was reduced from
11 to 0 per cent between the first 32 and later operations.
Performance can be studied more objectively using surgi-
cal simulation models for laparoscopic training. Standard
training for laparoscopic inguinal and ventral hernia repair,
including 1 day each of lectures, simulation training and
surgery, has been reported to result in similar surgical out-
comes for trainees and consultants, except for longer oper-
ations among trainees120.
Evidence concerning the learning curve for umbilical
and epigastric hernia repairs is limited. The number of
procedures necessary before a trainee can perform the
procedure safely and independently has not been assessed.
It seems advantageous to include simulation training in
the teaching of laparoscopic ventral hernia repair. For
laparoscopic repairs, the complication and recurrence rates
seem to decrease after around 30 procedures. For open
repairs, the guideline group suggested that the learning
curve is reached after around 20 procedures.
KQ 18: How can costs for umbilical and epigastric
hernia repair be influenced?
Statement: Costs for umbilical and epigastric hernia
repair will increase when wound complications and
recurrence occur. Costs may be reduced by preoperative
optimization, by using a low-cost permanent flat mesh,
and by reserving the laparoscopic technique for patients
with defects larger than 4 cm or at high risk of wound
complications.
Recommendation: To reduce the costs of umbilical and
epigastric hernia repair, it is suggested that open repair
should be done with a preperitoneal flat mesh as a day
case, with the utmost effort to reduce potential compli-
cations such as infection and recurrence by considering
preoperative optimization and tailoring the approach.
Quality of evidence:
Strength of recommendation: Weak
Overall costs of ventral hernia repair include pretreat-
ment, treatment and post-treatment care. From a financial
perspective, expenses are variable. These can be trimmed
by prehabilitation, and appropriate choice of surgical tech-
nique and mesh type. Most of the available literature
includes incisional and complex hernias; it is a challenge to
find evidence for the most cost-effective treatment strategy
for umbilical and epigastric hernias.
Pretreatment
The aim of prehabilitation is to avoid complications,
such as infection and recurrence, which will minimize
potential cost. For open ventral hernia repair of large
defects, patients with preventable co-morbidities such as
diabetes, obesity and smoking are more likely to experience
wound-related complications121. Whether reducing pre-
ventable co-morbidities can improve outcomes after repair
of small umbilical and epigastric hernias is unknown.
Treatment
The costs of surgical treatment, including operating the-
atre costs, ultimately serve as the most significant finan-
cial burden. Appropriate patient selection and surgical
decision-making, therefore, hold the largest potential for
overall cost reduction. Various factors can influence the net
cost of a procedure: laparoscopic versus open repair, outpa-
tient versus inpatient setting, type of medical equipment,
type of mesh and experience of the surgeon.
The costs of non-surgical and surgical treatment of
umbilical hernia have been compared, and the direct finan-
cial costs of umbilical hernia repair were higher in the
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first year after surgery122. In patients who were chosen for
non-operative management, days of healthcare utilization
and estimated time off work were higher. The difference
in cost between the groups reduced considerably over time.
With longer follow-up, costs in the non-surgery group may
surpass those in the surgery group122.
In analyses including all types of ventral hernia, laparo-
scopic repair was associated with fewer complications,
shorter duration of hospital stay, fewer readmissions, fewer
outpatient appointments and fewer days off work than
open repair105,123,124. These conclusions could differ signif-
icantly if only small or medium-sized primary ventral her-
nias are considered. Laparoscopic repair decreases wound
complications and is particularly indicated in patients at
increased risk of infection86.
The notorious discussion about mesh type serves as a
hallmark debate in the ventral hernia repair literature.
Certain meshes or preformed patches for intraperitoneal
use are more expensive as they are coated with antiadhesive
barriers. In comparisons of the use of a preformed patch
versus a basic flat mesh for umbilical and epigastric hernia
repair, the operating time was shorter when a preformed
patch was used, but the complication rate was higher64,65.
The primary goal of umbilical and epigastric hernia
repair should be a successful primary repair, avoiding com-
plications and recurrences. In general, both complications
and recurrence add substantially to total costs and resource
use125.
Taken together, most of the literature describes the costs
of treatment of all ventral hernias (including incisional her-
nias). Making firm conclusions about umbilical and epi-
gastric repairs alone is a challenge. It is recommended to
consider prehabilitation, offer day-case surgery and opti-
mal treatment strategies that decrease the risk of complica-
tions.
Comments
This international guideline covers the treatment of umbil-
ical and epigastric hernias alone. The literature specifically
on umbilical and epigastric hernias is limited in both quan-
tity and quality. For some key questions, it was necessary
to extrapolate data from studies reporting both incisional
and primary ventral hernias. Therefore, most recommen-
dations are weak, which is a significant limitation of the
guideline. The only strong recommendation based on a
high quality of evidence was to use mesh for defects of at
least 1 cm to reduce recurrence. Recurrence was the most
frequent outcome studied; data on patient-reported out-
comes were lacking. Nevertheless, based on a thorough
review of the available literature and expert opinions from
the guideline group, a treatment algorithm for umbilical
and epigastric hernias is suggested.
For small umbilical and epigastric hernias (0–1 cm),
either open mesh repair or a sutured repair can be used.
For symptomatic, medium-sized hernias (more than 1 cm
up to 4 cm), open repair with a preperitoneal flat mesh
is recommended. This technique is feasible and cheap,
and is indicated in high-income as well as in middle- and
low-income regions. Laparoscopic repair is recommended
for large defects (over 4 cm), in obese patients, or for mul-
tiple defects.
Perspectives
The majority of the recommendations in the current guide-
line are weak, as there was a lack of direct evidence
on umbilical and epigastric hernia repairs. The guideline
group discussed and proposed some future studies that
could lead to a change of practice. First, it is important
to define an agreed minimum set of outcomes (core out-
come set) that clearly outlines what patients and surgeons
find important about the various techniques. Furthermore,
pooling of primary ventral and incisional hernias should
be avoided, to generate specific conclusions for each her-
nia type.
Future studies could be RCTs, which often require
resources in money and time, with answers expected only
after many years, and a risk of low external validity. Alter-
natively, an increasing number of registries are generating
high-quality data with high external validity. Other alterna-
tives are the multiarm multistage framework or trials within
cohorts, which are efficient ways of evaluating treatment
strategies and measuring outcomes in a large cohort.
It is unknown whether preoperative optimization of
patients with preventable co-morbidities could decrease
postoperative complications and recurrence. A database
study could possibly answer these questions. The value of
single-dose antibiotic prophylaxis in reducing postopera-
tive wound complications should be examined in an RCT
setting.
Concerning surgical technique for umbilical and epi-
gastric hernia repair, further studies are needed to clarify
whether defects of smaller than 1 cm benefit from mesh
repair. For defects larger than 1 cm up to 4 cm, it would
be of value to know whether laparoscopic or open repair
is optimal. Furthermore, for open repair of small and
medium-sized umbilical and epigastric hernias, the opti-
mal mesh layer, size of mesh overlap, and whether or not
the defect should be closed are unknown factors that could
influence outcomes, and which could be assessed in either
© 2020 BJS Society Ltd www.bjs.co.uk BJS 2020; 107: 171–190
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database studies or RCTs. The potential benefits of clo-
sure of the defect in combination with mesh in different
positions in the abdominal wall is also unclear, and could
potentially be explored in large registry-based studies. The
role of the novel laparoendoscopic and robot-assisted tech-
niques also needs to be clarified for umbilical and epigastric
hernia repair. Large database studies might be a useful ini-
tial approach in evaluating these technologies.
An update of the guideline is planned for 2023. Sig-
nificant results from new research that would change the
current recommendations are not likely to be available
before this.
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